SCHEMBL5756243

SCHEMBL5756243

NC(=NO)c1ccc2c(=O)c3c(sc2c1)CCCCCC3

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.34
FLT3 P36888 9/20 0.34
KMT2A Q03164 3/20 0.34
ALDH1A1 P00352 2/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 2/20 0.34
MEN1 O00255 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALOX15 P16050 1/20 0.34
MAPK1 P28482 1/20 0.34
HSD17B10 Q99714 1/20 0.34
LMNA P02545 1/20 0.33
GAA P10253 1/20 0.33
CLK1 P49759 1/20 0.33
GFER P55789 1/20 0.33
RECQL P46063 1/20 0.33
POLB P06746 1/20 0.33
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5756237 1.00 TDP1 (0.34) TDP1FLT3KMT2AALDH1A1MAPT
SCHEMBL5740679 0.82 ALDH1A1 (0.40) TDP1KMT2AALDH1A1MAPTHPGD
SCHEMBL6689643 0.80 ABCC1 (0.41) TDP1KMT2AALDH1A1MAPTHPGD
SCHEMBL5739313 0.80 PDE4B (0.33) RECQL
SCHEMBL5739316 0.80 PDE4B (0.33) RECQL
SCHEMBL5741511 0.78 TNIK (0.39) KMT2AALDH1A1MAPTHPGDMEN1
SCHEMBL5741510 0.78 TNIK (0.39) KMT2AALDH1A1MAPTHPGDMEN1
SCHEMBL5756239 0.78 TNF (0.34) TDP1FLT3KMT2AALDH1A1MAPT
SCHEMBL5741304 0.74 HSD17B10 (0.44) FLT3KMT2AALDH1A1MAPTMEN1
SCHEMBL5738977 0.71 ALDH1A1 (0.38) KMT2AALDH1A1MAPTHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1152741-B1 STABILIZED ANTIMICROBIAL SYSTEMS AND METHODS OF MAKING THE SAME ETHICON INC (US) 2006-10-25 EP claimed
EP-1406891-B1 THIOCHROMENONES USED TO COMBAT PAINFUL CONDITIONS AND NEURODEGENERATIVE DISEASES BAYER HEALTHCARE AG (DE) 2006-03-22 EP disclosed
US-20050009820-A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases BAYER HEALTHCARE AG (DE) 2005-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009820-A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases HTT, HMOX1, SNCA TDP1 115/4885FLT3 4564/4885KMT2A 3255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.